3

PRIMARY DOCUMENT

Company: ALNYLAM PHARMACEUTICALS, INC.
Filed: December 22, 2015
Period of Report: December 18, 2015
Accession Number: 0001325812-15-000060

View Document ↗ View on SEC.gov ↗